Clinical applications of mifepristone (RU 486) and other antiprogestins :: assessing the science and recommending a research agenda /
Gespeichert in:
| Körperschaften: | , |
|---|---|
| Weitere Verfasser: | , |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C. :
National Academy Press,
1993.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | "Support for this project was provided by a grant from the Henry J. Kaiser Family Foundation, Menlo Park, California."--Title page verso. Committee chairman: Leslie Z. Benet. |
| Beschreibung: | 1 online resource (xi, 288 pages) : illustrations |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 0585024782 9780585024783 1280196025 9781280196027 9786610196029 6610196028 0309598354 9780309598354 |
Internformat
MARC
| LEADER | 00000cam a2200000Ma 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocm42329097 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 931027s1993 dcua ob 001 0 eng d | ||
| 010 | |z 93085360 | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCL |d OCLCQ |d YDXCP |d OCLCQ |d NTE |d OCLCQ |d TUU |d OCLCQ |d TNF |d OCLCQ |d UV0 |d CUSER |d E7B |d IDEBK |d CUS |d WVH |d OCLCQ |d OCLCO |d DKDLA |d OCLCQ |d COO |d NLGGC |d OCLCQ |d AZK |d OCLCQ |d VT2 |d MWM |d OCLCO |d TOA |d OCLCO |d AGLDB |d MOR |d PIFBR |d XFH |d OCLCQ |d OCLCA |d U3W |d OCLCA |d OCLCQ |d BUF |d OCLCO |d LUE |d STF |d WRM |d OCLCQ |d VTS |d COCUF |d OCLCO |d TOF |d NRAMU |d INT |d OCLCQ |d AU@ |d OCLCQ |d WYU |d OCLCQ |d UKAHL |d M8D |d KIJ |d UKBTH |d DST |d AAA |d OCLCO |d OCLCF |d LUU |d TNZ |d INARC |d OCLCA |d OCLCQ |d CJT |d OCLCQ |d OCLCO |d OCLCL | ||
| 019 | |a 228064163 |a 326709854 |a 647367446 |a 666928803 |a 698448129 |a 722262434 |a 888492662 |a 961491743 |a 961609004 |a 962577092 |a 962699550 |a 970749169 |a 988468854 |a 992074398 |a 994498766 |a 1037908569 |a 1038582312 |a 1045521185 |a 1059036018 |a 1062938301 |a 1081187501 |a 1097105128 |a 1156385905 |a 1159618591 |a 1228617756 |a 1241811389 |a 1249226893 |a 1259237770 |a 1290107936 |a 1300595087 |a 1303388202 |a 1303459810 |a 1306560528 |a 1373446960 |a 1378240696 |a 1397471641 |a 1409719824 |a 1438704815 |a 1450138698 | ||
| 020 | |a 0585024782 |q (electronic bk.) | ||
| 020 | |a 9780585024783 |q (electronic bk.) | ||
| 020 | |a 1280196025 | ||
| 020 | |a 9781280196027 | ||
| 020 | |a 9786610196029 | ||
| 020 | |a 6610196028 | ||
| 020 | |a 0309598354 | ||
| 020 | |a 9780309598354 | ||
| 020 | |z 0309049490 | ||
| 020 | |z 9780309049498 |q (pbk.) | ||
| 035 | |a (OCoLC)42329097 |z (OCoLC)228064163 |z (OCoLC)326709854 |z (OCoLC)647367446 |z (OCoLC)666928803 |z (OCoLC)698448129 |z (OCoLC)722262434 |z (OCoLC)888492662 |z (OCoLC)961491743 |z (OCoLC)961609004 |z (OCoLC)962577092 |z (OCoLC)962699550 |z (OCoLC)970749169 |z (OCoLC)988468854 |z (OCoLC)992074398 |z (OCoLC)994498766 |z (OCoLC)1037908569 |z (OCoLC)1038582312 |z (OCoLC)1045521185 |z (OCoLC)1059036018 |z (OCoLC)1062938301 |z (OCoLC)1081187501 |z (OCoLC)1097105128 |z (OCoLC)1156385905 |z (OCoLC)1159618591 |z (OCoLC)1228617756 |z (OCoLC)1241811389 |z (OCoLC)1249226893 |z (OCoLC)1259237770 |z (OCoLC)1290107936 |z (OCoLC)1300595087 |z (OCoLC)1303388202 |z (OCoLC)1303459810 |z (OCoLC)1306560528 |z (OCoLC)1373446960 |z (OCoLC)1378240696 |z (OCoLC)1397471641 |z (OCoLC)1409719824 |z (OCoLC)1438704815 |z (OCoLC)1450138698 | ||
| 050 | 4 | |a RG137.6.M53 |b C57 1993eb | |
| 060 | 4 | |a 1994 B-064 | |
| 060 | 4 | |a QV 175 C641 1993 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 7 | |a 615/.766 |2 20 | |
| 084 | |a XI 5203 |2 rvk | ||
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Clinical applications of mifepristone (RU 486) and other antiprogestins : |b assessing the science and recommending a research agenda / |c Committee on Antiprogestins: Assessing the Science, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Molla S. Donaldson [and others], editors. |
| 260 | |a Washington, D.C. : |b National Academy Press, |c 1993. | ||
| 300 | |a 1 online resource (xi, 288 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 500 | |a "Support for this project was provided by a grant from the Henry J. Kaiser Family Foundation, Menlo Park, California."--Title page verso. | ||
| 500 | |a Committee chairman: Leslie Z. Benet. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Background and historical perspectives -- IOM report -- Cross-cutting recommendations -- Uses of antiprogestins: the reproductive cycle -- Contraception -- Post-coital contraception -- Menses induction -- Uses of antiprogestins: the reproductive cycle -- Pregnancy termination during the first trimester -- Pregnancy termination during the second trimester -- Cervical ripening -- Labor induction in late pregnancy -- Other therapeutic uses of antiprogestins -- Endometriosis -- Uterine leiomyomas (fibroids) -- Breast cancer -- Meningiomas -- Antiglucocorticoid effects of antiprogestins -- Glucocorticoid function -- Therapeutic use of mifepristone (RU 486) as an antiglucocorticoid -- Adverse antiglucocorticoid effects of antiprogestins -- Animals as models for studying antiprogestins -- Agenda for the IOM workshop "Antiprogestins: Assessing the Science" -- Background papers and presentations (in order of presentation at IOM workshop) -- 1993: RU 486: a decade on today and tomorrow / Etienne-Emile Baulieu. | |
| 505 | 0 | |a (cont) Overview and background: mechanism of action of antiprogestins / Nancy L. Weigel -- Use of antiprogestins in the reproductive cycle / Lynnette Kaye Nieman -- Potential contraceptive effects of antigestogens / David T. Baird -- Use of antiprogestins before 63 days of amenorrhea / Marc Bygdeman -- Uses of antiprogestins after 63 days of amenorrhea / Ancre Ulmann and Louise Silvestre -- Comments on session II -- David Grimes -- Use of antiprogestins in the management of endometriosis and leiomyoma / Samuel S.C. Yen -- Antiprogestins and the treatment of breast cancer / Kathryn B. Horwitz -- Uses of RU 486 as an antiglucocorticoid / Lynnette Kaye Nieman -- Primate models for the study of antiprogestins in reproductive medicine / Gary D. Hodgen -- Antiprogestogens: perspectives from a global research program / P.F.A. Van Look and H. von Hertzen -- Observers at the workshop on antiprogestins. | |
| 588 | 0 | |a Print version record. | |
| 546 | |a English. | ||
| 650 | 0 | |a Mifepristone |x Research. | |
| 650 | 0 | |a Abortifacients |x Research. | |
| 650 | 0 | |a Progesterone |x Antagonists |x Research. | |
| 650 | 0 | |a Mifepristone. |0 http://id.loc.gov/authorities/subjects/sh85085059 | |
| 650 | 0 | |a Abortifacients. |0 http://id.loc.gov/authorities/subjects/sh85000195 | |
| 650 | 1 | 2 | |a Mifepristone |
| 650 | 1 | 2 | |a Abortifacient Agents |
| 650 | 2 | 2 | |a Progesterone |x antagonists & inhibitors |
| 650 | 6 | |a Mifépristone |x Recherche. | |
| 650 | 6 | |a Abortifs |x Recherche. | |
| 650 | 6 | |a Antiprogestérones |x Recherche. | |
| 650 | 6 | |a Mifépristone. | |
| 650 | 6 | |a Abortifs. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Abortifacients |2 fast | |
| 650 | 7 | |a Mifepristone |2 fast | |
| 650 | 7 | |a RU 486 |2 gnd | |
| 700 | 1 | |a Benet, Leslie Z. |0 http://id.loc.gov/authorities/names/n83004972 | |
| 700 | 1 | |a Donaldson, Molla S. |0 http://id.loc.gov/authorities/names/n91081107 | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Committee on Antiprogestins: Assessing the Science. |0 http://id.loc.gov/authorities/names/n93107126 | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Division of Health Promotion and Disease Prevention. |0 http://id.loc.gov/authorities/names/n80156868 | |
| 758 | |i has work: |a Clinical applications of mifepristone (RU 486) and other antiprogestins (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGhtD8xFJw9GhMRrfF3CwC |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Clinical applications of mifepristone (RU 486) and other antiprogestins. |d Washington, D.C. : National Academy Press, 1993 |z 0309049490 |w (DLC) 93085360 |w (OCoLC)28761657 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36567580 | ||
| 938 | |a ebrary |b EBRY |n ebr10056944 | ||
| 938 | |a EBSCOhost |b EBSC |n 783 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 19602 | ||
| 938 | |a YBP Library Services |b YANK |n 2302888 | ||
| 938 | |a YBP Library Services |b YANK |n 6013090 | ||
| 938 | |a Internet Archive |b INAR |n clinicalapplicat0000unse_y1v7 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocm42329097 |
|---|---|
| _version_ | 1816881574277283841 |
| adam_text | |
| any_adam_object | |
| author2 | Benet, Leslie Z. Donaldson, Molla S. |
| author2_role | |
| author2_variant | l z b lz lzb m s d ms msd |
| author_GND | http://id.loc.gov/authorities/names/n83004972 http://id.loc.gov/authorities/names/n91081107 |
| author_corporate | Institute of Medicine (U.S.). Committee on Antiprogestins: Assessing the Science Institute of Medicine (U.S.). Division of Health Promotion and Disease Prevention |
| author_corporate_role | |
| author_facet | Benet, Leslie Z. Donaldson, Molla S. Institute of Medicine (U.S.). Committee on Antiprogestins: Assessing the Science Institute of Medicine (U.S.). Division of Health Promotion and Disease Prevention |
| author_sort | Benet, Leslie Z. |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RG137 |
| callnumber-raw | RG137.6.M53 C57 1993eb |
| callnumber-search | RG137.6.M53 C57 1993eb |
| callnumber-sort | RG 3137.6 M53 C57 41993EB |
| callnumber-subject | RG - Gynecology and Obstetrics |
| classification_rvk | XI 5203 |
| collection | ZDB-4-EBA |
| contents | Background and historical perspectives -- IOM report -- Cross-cutting recommendations -- Uses of antiprogestins: the reproductive cycle -- Contraception -- Post-coital contraception -- Menses induction -- Uses of antiprogestins: the reproductive cycle -- Pregnancy termination during the first trimester -- Pregnancy termination during the second trimester -- Cervical ripening -- Labor induction in late pregnancy -- Other therapeutic uses of antiprogestins -- Endometriosis -- Uterine leiomyomas (fibroids) -- Breast cancer -- Meningiomas -- Antiglucocorticoid effects of antiprogestins -- Glucocorticoid function -- Therapeutic use of mifepristone (RU 486) as an antiglucocorticoid -- Adverse antiglucocorticoid effects of antiprogestins -- Animals as models for studying antiprogestins -- Agenda for the IOM workshop "Antiprogestins: Assessing the Science" -- Background papers and presentations (in order of presentation at IOM workshop) -- 1993: RU 486: a decade on today and tomorrow / Etienne-Emile Baulieu. (cont) Overview and background: mechanism of action of antiprogestins / Nancy L. Weigel -- Use of antiprogestins in the reproductive cycle / Lynnette Kaye Nieman -- Potential contraceptive effects of antigestogens / David T. Baird -- Use of antiprogestins before 63 days of amenorrhea / Marc Bygdeman -- Uses of antiprogestins after 63 days of amenorrhea / Ancre Ulmann and Louise Silvestre -- Comments on session II -- David Grimes -- Use of antiprogestins in the management of endometriosis and leiomyoma / Samuel S.C. Yen -- Antiprogestins and the treatment of breast cancer / Kathryn B. Horwitz -- Uses of RU 486 as an antiglucocorticoid / Lynnette Kaye Nieman -- Primate models for the study of antiprogestins in reproductive medicine / Gary D. Hodgen -- Antiprogestogens: perspectives from a global research program / P.F.A. Van Look and H. von Hertzen -- Observers at the workshop on antiprogestins. |
| ctrlnum | (OCoLC)42329097 |
| dewey-full | 615/.766 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.766 |
| dewey-search | 615/.766 |
| dewey-sort | 3615 3766 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>07533cam a2200901Ma 4500</leader><controlfield tag="001">ZDB-4-EBA-ocm42329097 </controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">931027s1993 dcua ob 001 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 93085360 </subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NTE</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">TUU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">TNF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">UV0</subfield><subfield code="d">CUSER</subfield><subfield code="d">E7B</subfield><subfield code="d">IDEBK</subfield><subfield code="d">CUS</subfield><subfield code="d">WVH</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">DKDLA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">COO</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AZK</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VT2</subfield><subfield code="d">MWM</subfield><subfield code="d">OCLCO</subfield><subfield code="d">TOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFBR</subfield><subfield code="d">XFH</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">BUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">LUE</subfield><subfield code="d">STF</subfield><subfield code="d">WRM</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">COCUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">TOF</subfield><subfield code="d">NRAMU</subfield><subfield code="d">INT</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">UKAHL</subfield><subfield code="d">M8D</subfield><subfield code="d">KIJ</subfield><subfield code="d">UKBTH</subfield><subfield code="d">DST</subfield><subfield code="d">AAA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">LUU</subfield><subfield code="d">TNZ</subfield><subfield code="d">INARC</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">CJT</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">228064163</subfield><subfield code="a">326709854</subfield><subfield code="a">647367446</subfield><subfield code="a">666928803</subfield><subfield code="a">698448129</subfield><subfield code="a">722262434</subfield><subfield code="a">888492662</subfield><subfield code="a">961491743</subfield><subfield code="a">961609004</subfield><subfield code="a">962577092</subfield><subfield code="a">962699550</subfield><subfield code="a">970749169</subfield><subfield code="a">988468854</subfield><subfield code="a">992074398</subfield><subfield code="a">994498766</subfield><subfield code="a">1037908569</subfield><subfield code="a">1038582312</subfield><subfield code="a">1045521185</subfield><subfield code="a">1059036018</subfield><subfield code="a">1062938301</subfield><subfield code="a">1081187501</subfield><subfield code="a">1097105128</subfield><subfield code="a">1156385905</subfield><subfield code="a">1159618591</subfield><subfield code="a">1228617756</subfield><subfield code="a">1241811389</subfield><subfield code="a">1249226893</subfield><subfield code="a">1259237770</subfield><subfield code="a">1290107936</subfield><subfield code="a">1300595087</subfield><subfield code="a">1303388202</subfield><subfield code="a">1303459810</subfield><subfield code="a">1306560528</subfield><subfield code="a">1373446960</subfield><subfield code="a">1378240696</subfield><subfield code="a">1397471641</subfield><subfield code="a">1409719824</subfield><subfield code="a">1438704815</subfield><subfield code="a">1450138698</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0585024782</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780585024783</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1280196025</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781280196027</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786610196029</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6610196028</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309598354</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309598354</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309049490</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309049498</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)42329097</subfield><subfield code="z">(OCoLC)228064163</subfield><subfield code="z">(OCoLC)326709854</subfield><subfield code="z">(OCoLC)647367446</subfield><subfield code="z">(OCoLC)666928803</subfield><subfield code="z">(OCoLC)698448129</subfield><subfield code="z">(OCoLC)722262434</subfield><subfield code="z">(OCoLC)888492662</subfield><subfield code="z">(OCoLC)961491743</subfield><subfield code="z">(OCoLC)961609004</subfield><subfield code="z">(OCoLC)962577092</subfield><subfield code="z">(OCoLC)962699550</subfield><subfield code="z">(OCoLC)970749169</subfield><subfield code="z">(OCoLC)988468854</subfield><subfield code="z">(OCoLC)992074398</subfield><subfield code="z">(OCoLC)994498766</subfield><subfield code="z">(OCoLC)1037908569</subfield><subfield code="z">(OCoLC)1038582312</subfield><subfield code="z">(OCoLC)1045521185</subfield><subfield code="z">(OCoLC)1059036018</subfield><subfield code="z">(OCoLC)1062938301</subfield><subfield code="z">(OCoLC)1081187501</subfield><subfield code="z">(OCoLC)1097105128</subfield><subfield code="z">(OCoLC)1156385905</subfield><subfield code="z">(OCoLC)1159618591</subfield><subfield code="z">(OCoLC)1228617756</subfield><subfield code="z">(OCoLC)1241811389</subfield><subfield code="z">(OCoLC)1249226893</subfield><subfield code="z">(OCoLC)1259237770</subfield><subfield code="z">(OCoLC)1290107936</subfield><subfield code="z">(OCoLC)1300595087</subfield><subfield code="z">(OCoLC)1303388202</subfield><subfield code="z">(OCoLC)1303459810</subfield><subfield code="z">(OCoLC)1306560528</subfield><subfield code="z">(OCoLC)1373446960</subfield><subfield code="z">(OCoLC)1378240696</subfield><subfield code="z">(OCoLC)1397471641</subfield><subfield code="z">(OCoLC)1409719824</subfield><subfield code="z">(OCoLC)1438704815</subfield><subfield code="z">(OCoLC)1450138698</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RG137.6.M53</subfield><subfield code="b">C57 1993eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">1994 B-064</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QV 175 C641 1993</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">071000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615/.766</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5203</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Clinical applications of mifepristone (RU 486) and other antiprogestins :</subfield><subfield code="b">assessing the science and recommending a research agenda /</subfield><subfield code="c">Committee on Antiprogestins: Assessing the Science, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Molla S. Donaldson [and others], editors.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academy Press,</subfield><subfield code="c">1993.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xi, 288 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield><subfield code="2">rda</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Support for this project was provided by a grant from the Henry J. Kaiser Family Foundation, Menlo Park, California."--Title page verso.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Committee chairman: Leslie Z. Benet.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Background and historical perspectives -- IOM report -- Cross-cutting recommendations -- Uses of antiprogestins: the reproductive cycle -- Contraception -- Post-coital contraception -- Menses induction -- Uses of antiprogestins: the reproductive cycle -- Pregnancy termination during the first trimester -- Pregnancy termination during the second trimester -- Cervical ripening -- Labor induction in late pregnancy -- Other therapeutic uses of antiprogestins -- Endometriosis -- Uterine leiomyomas (fibroids) -- Breast cancer -- Meningiomas -- Antiglucocorticoid effects of antiprogestins -- Glucocorticoid function -- Therapeutic use of mifepristone (RU 486) as an antiglucocorticoid -- Adverse antiglucocorticoid effects of antiprogestins -- Animals as models for studying antiprogestins -- Agenda for the IOM workshop "Antiprogestins: Assessing the Science" -- Background papers and presentations (in order of presentation at IOM workshop) -- 1993: RU 486: a decade on today and tomorrow / Etienne-Emile Baulieu.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">(cont) Overview and background: mechanism of action of antiprogestins / Nancy L. Weigel -- Use of antiprogestins in the reproductive cycle / Lynnette Kaye Nieman -- Potential contraceptive effects of antigestogens / David T. Baird -- Use of antiprogestins before 63 days of amenorrhea / Marc Bygdeman -- Uses of antiprogestins after 63 days of amenorrhea / Ancre Ulmann and Louise Silvestre -- Comments on session II -- David Grimes -- Use of antiprogestins in the management of endometriosis and leiomyoma / Samuel S.C. Yen -- Antiprogestins and the treatment of breast cancer / Kathryn B. Horwitz -- Uses of RU 486 as an antiglucocorticoid / Lynnette Kaye Nieman -- Primate models for the study of antiprogestins in reproductive medicine / Gary D. Hodgen -- Antiprogestogens: perspectives from a global research program / P.F.A. Van Look and H. von Hertzen -- Observers at the workshop on antiprogestins.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Mifepristone</subfield><subfield code="x">Research.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Abortifacients</subfield><subfield code="x">Research.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Progesterone</subfield><subfield code="x">Antagonists</subfield><subfield code="x">Research.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Mifepristone.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85085059</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Abortifacients.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85000195</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Mifepristone</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Abortifacient Agents</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Progesterone</subfield><subfield code="x">antagonists & inhibitors</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Mifépristone</subfield><subfield code="x">Recherche.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Abortifs</subfield><subfield code="x">Recherche.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Antiprogestérones</subfield><subfield code="x">Recherche.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Mifépristone.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Abortifs.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Abortifacients</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Mifepristone</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RU 486</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Benet, Leslie Z.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n83004972</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Donaldson, Molla S.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n91081107</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Committee on Antiprogestins: Assessing the Science.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n93107126</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Division of Health Promotion and Disease Prevention.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n80156868</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Clinical applications of mifepristone (RU 486) and other antiprogestins (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGhtD8xFJw9GhMRrfF3CwC</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Clinical applications of mifepristone (RU 486) and other antiprogestins.</subfield><subfield code="d">Washington, D.C. : National Academy Press, 1993</subfield><subfield code="z">0309049490</subfield><subfield code="w">(DLC) 93085360</subfield><subfield code="w">(OCoLC)28761657</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36567580</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10056944</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">783</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">19602</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">2302888</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">6013090</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Internet Archive</subfield><subfield code="b">INAR</subfield><subfield code="n">clinicalapplicat0000unse_y1v7</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocm42329097 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:14:53Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/n93107126 http://id.loc.gov/authorities/names/n80156868 |
| isbn | 0585024782 9780585024783 1280196025 9781280196027 9786610196029 6610196028 0309598354 9780309598354 |
| language | English |
| oclc_num | 42329097 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (xi, 288 pages) : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | National Academy Press, |
| record_format | marc |
| spelling | Clinical applications of mifepristone (RU 486) and other antiprogestins : assessing the science and recommending a research agenda / Committee on Antiprogestins: Assessing the Science, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Molla S. Donaldson [and others], editors. Washington, D.C. : National Academy Press, 1993. 1 online resource (xi, 288 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier data file rda "Support for this project was provided by a grant from the Henry J. Kaiser Family Foundation, Menlo Park, California."--Title page verso. Committee chairman: Leslie Z. Benet. Includes bibliographical references and index. Background and historical perspectives -- IOM report -- Cross-cutting recommendations -- Uses of antiprogestins: the reproductive cycle -- Contraception -- Post-coital contraception -- Menses induction -- Uses of antiprogestins: the reproductive cycle -- Pregnancy termination during the first trimester -- Pregnancy termination during the second trimester -- Cervical ripening -- Labor induction in late pregnancy -- Other therapeutic uses of antiprogestins -- Endometriosis -- Uterine leiomyomas (fibroids) -- Breast cancer -- Meningiomas -- Antiglucocorticoid effects of antiprogestins -- Glucocorticoid function -- Therapeutic use of mifepristone (RU 486) as an antiglucocorticoid -- Adverse antiglucocorticoid effects of antiprogestins -- Animals as models for studying antiprogestins -- Agenda for the IOM workshop "Antiprogestins: Assessing the Science" -- Background papers and presentations (in order of presentation at IOM workshop) -- 1993: RU 486: a decade on today and tomorrow / Etienne-Emile Baulieu. (cont) Overview and background: mechanism of action of antiprogestins / Nancy L. Weigel -- Use of antiprogestins in the reproductive cycle / Lynnette Kaye Nieman -- Potential contraceptive effects of antigestogens / David T. Baird -- Use of antiprogestins before 63 days of amenorrhea / Marc Bygdeman -- Uses of antiprogestins after 63 days of amenorrhea / Ancre Ulmann and Louise Silvestre -- Comments on session II -- David Grimes -- Use of antiprogestins in the management of endometriosis and leiomyoma / Samuel S.C. Yen -- Antiprogestins and the treatment of breast cancer / Kathryn B. Horwitz -- Uses of RU 486 as an antiglucocorticoid / Lynnette Kaye Nieman -- Primate models for the study of antiprogestins in reproductive medicine / Gary D. Hodgen -- Antiprogestogens: perspectives from a global research program / P.F.A. Van Look and H. von Hertzen -- Observers at the workshop on antiprogestins. Print version record. English. Mifepristone Research. Abortifacients Research. Progesterone Antagonists Research. Mifepristone. http://id.loc.gov/authorities/subjects/sh85085059 Abortifacients. http://id.loc.gov/authorities/subjects/sh85000195 Mifepristone Abortifacient Agents Progesterone antagonists & inhibitors Mifépristone Recherche. Abortifs Recherche. Antiprogestérones Recherche. Mifépristone. Abortifs. MEDICAL Pharmacology. bisacsh Abortifacients fast Mifepristone fast RU 486 gnd Benet, Leslie Z. http://id.loc.gov/authorities/names/n83004972 Donaldson, Molla S. http://id.loc.gov/authorities/names/n91081107 Institute of Medicine (U.S.). Committee on Antiprogestins: Assessing the Science. http://id.loc.gov/authorities/names/n93107126 Institute of Medicine (U.S.). Division of Health Promotion and Disease Prevention. http://id.loc.gov/authorities/names/n80156868 has work: Clinical applications of mifepristone (RU 486) and other antiprogestins (Text) https://id.oclc.org/worldcat/entity/E39PCGhtD8xFJw9GhMRrfF3CwC https://id.oclc.org/worldcat/ontology/hasWork Print version: Clinical applications of mifepristone (RU 486) and other antiprogestins. Washington, D.C. : National Academy Press, 1993 0309049490 (DLC) 93085360 (OCoLC)28761657 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783 Volltext |
| spellingShingle | Clinical applications of mifepristone (RU 486) and other antiprogestins : assessing the science and recommending a research agenda / Background and historical perspectives -- IOM report -- Cross-cutting recommendations -- Uses of antiprogestins: the reproductive cycle -- Contraception -- Post-coital contraception -- Menses induction -- Uses of antiprogestins: the reproductive cycle -- Pregnancy termination during the first trimester -- Pregnancy termination during the second trimester -- Cervical ripening -- Labor induction in late pregnancy -- Other therapeutic uses of antiprogestins -- Endometriosis -- Uterine leiomyomas (fibroids) -- Breast cancer -- Meningiomas -- Antiglucocorticoid effects of antiprogestins -- Glucocorticoid function -- Therapeutic use of mifepristone (RU 486) as an antiglucocorticoid -- Adverse antiglucocorticoid effects of antiprogestins -- Animals as models for studying antiprogestins -- Agenda for the IOM workshop "Antiprogestins: Assessing the Science" -- Background papers and presentations (in order of presentation at IOM workshop) -- 1993: RU 486: a decade on today and tomorrow / Etienne-Emile Baulieu. (cont) Overview and background: mechanism of action of antiprogestins / Nancy L. Weigel -- Use of antiprogestins in the reproductive cycle / Lynnette Kaye Nieman -- Potential contraceptive effects of antigestogens / David T. Baird -- Use of antiprogestins before 63 days of amenorrhea / Marc Bygdeman -- Uses of antiprogestins after 63 days of amenorrhea / Ancre Ulmann and Louise Silvestre -- Comments on session II -- David Grimes -- Use of antiprogestins in the management of endometriosis and leiomyoma / Samuel S.C. Yen -- Antiprogestins and the treatment of breast cancer / Kathryn B. Horwitz -- Uses of RU 486 as an antiglucocorticoid / Lynnette Kaye Nieman -- Primate models for the study of antiprogestins in reproductive medicine / Gary D. Hodgen -- Antiprogestogens: perspectives from a global research program / P.F.A. Van Look and H. von Hertzen -- Observers at the workshop on antiprogestins. Mifepristone Research. Abortifacients Research. Progesterone Antagonists Research. Mifepristone. http://id.loc.gov/authorities/subjects/sh85085059 Abortifacients. http://id.loc.gov/authorities/subjects/sh85000195 Mifepristone Abortifacient Agents Progesterone antagonists & inhibitors Mifépristone Recherche. Abortifs Recherche. Antiprogestérones Recherche. Mifépristone. Abortifs. MEDICAL Pharmacology. bisacsh Abortifacients fast Mifepristone fast RU 486 gnd |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85085059 http://id.loc.gov/authorities/subjects/sh85000195 |
| title | Clinical applications of mifepristone (RU 486) and other antiprogestins : assessing the science and recommending a research agenda / |
| title_auth | Clinical applications of mifepristone (RU 486) and other antiprogestins : assessing the science and recommending a research agenda / |
| title_exact_search | Clinical applications of mifepristone (RU 486) and other antiprogestins : assessing the science and recommending a research agenda / |
| title_full | Clinical applications of mifepristone (RU 486) and other antiprogestins : assessing the science and recommending a research agenda / Committee on Antiprogestins: Assessing the Science, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Molla S. Donaldson [and others], editors. |
| title_fullStr | Clinical applications of mifepristone (RU 486) and other antiprogestins : assessing the science and recommending a research agenda / Committee on Antiprogestins: Assessing the Science, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Molla S. Donaldson [and others], editors. |
| title_full_unstemmed | Clinical applications of mifepristone (RU 486) and other antiprogestins : assessing the science and recommending a research agenda / Committee on Antiprogestins: Assessing the Science, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Molla S. Donaldson [and others], editors. |
| title_short | Clinical applications of mifepristone (RU 486) and other antiprogestins : |
| title_sort | clinical applications of mifepristone ru 486 and other antiprogestins assessing the science and recommending a research agenda |
| title_sub | assessing the science and recommending a research agenda / |
| topic | Mifepristone Research. Abortifacients Research. Progesterone Antagonists Research. Mifepristone. http://id.loc.gov/authorities/subjects/sh85085059 Abortifacients. http://id.loc.gov/authorities/subjects/sh85000195 Mifepristone Abortifacient Agents Progesterone antagonists & inhibitors Mifépristone Recherche. Abortifs Recherche. Antiprogestérones Recherche. Mifépristone. Abortifs. MEDICAL Pharmacology. bisacsh Abortifacients fast Mifepristone fast RU 486 gnd |
| topic_facet | Mifepristone Research. Abortifacients Research. Progesterone Antagonists Research. Mifepristone. Abortifacients. Mifepristone Abortifacient Agents Progesterone antagonists & inhibitors Mifépristone Recherche. Abortifs Recherche. Antiprogestérones Recherche. Mifépristone. Abortifs. MEDICAL Pharmacology. Abortifacients RU 486 |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783 |
| work_keys_str_mv | AT benetlesliez clinicalapplicationsofmifepristoneru486andotherantiprogestinsassessingthescienceandrecommendingaresearchagenda AT donaldsonmollas clinicalapplicationsofmifepristoneru486andotherantiprogestinsassessingthescienceandrecommendingaresearchagenda AT instituteofmedicineuscommitteeonantiprogestinsassessingthescience clinicalapplicationsofmifepristoneru486andotherantiprogestinsassessingthescienceandrecommendingaresearchagenda AT instituteofmedicineusdivisionofhealthpromotionanddiseaseprevention clinicalapplicationsofmifepristoneru486andotherantiprogestinsassessingthescienceandrecommendingaresearchagenda |